In the race for a Covid-19 vaccine, here come the tortoises
Anyone handicapping the so-called competition to develop vaccines would do well to keep an eye on the players who seemingly got a late start.
Anyone handicapping the so-called competition to develop vaccines would do well to keep an eye on the players who seemingly got a late start.
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
A House subcommittee investigating the “lab leak” theory of Covid origins accuses EcoHealth of misrepresenting its virus research in Wuhan and pushes to deny it…
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
The company belatedly conceded both that it had paid the cybercriminals extorting it and that patient data nonetheless ended up on the dark web.
The DEA is allowing annual and semi-annual production quotas for Schedule II drugs, after it became clear quarterly quotas would worsen shortages.
Three years ago, Moderna invested part of its vaccine windfall into a new gene-editing startup, Metagenomi. Now it’s backing out.
Over the last decade, private equity firms acquired scores of wheelchair makers. Now, users routinely wait months to get their chairs repaired.
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.